Antimicrobial Resistance and Usage Patterns in Europe:
|
|
- Primrose Hines
- 5 years ago
- Views:
Transcription
1 Antimicrobial Resistance and Usage Patterns in Europe: Focus on Dutch-Belgian Differences and Complementarity & Lessons for the Future Dominique L. Monnet Antimicrobial Resistance Surveillance Unit, Dept. of Antimicrobial Resistance & Hospital Hygiene, Statens Serum Institut, Copenhagen, Denmark
2 MRSA in Europe, < 1% 1-2% 5.5% 2-29% 3-35% Source: Voss A, et al. Eur J Clin Microbiol Infect Dis 1994;13:5-55.
3 Methicillin-Resistant Staphylococcus aureus (MRSA) from Blood, 21 < 3% 3-9% 1-29% > 3% Source: EARSS. Available from: URL:
4 Ticarcillin-Resistant Pseudomonas aeruginosa in Europe (ICU NIs only), 1992 no data % 15-25% 5-65% 8% Source: EPIC Study (Régnier B. Pathol Biol 1996;44:113-23).
5 The World According to Human Bacterial Pathogens and Their Habitat Food Animals Humans Humans le MONDe de la Résistance Intrinsèque et Acquise aux ANtibiotiques ;-). H Pseudomonas aeruginosa Acinetobacter baumannii MRSA Salm. Camp. E. coli S. pneumoniae H. influenzae S. aureus E. coli S. aureus
6 Penicillin-Non Susceptible Streptococcus pneumoniae (PNSP) from Sterile Sites < 3% 3-9% 1-29% > 3% Source: EARSS. Available from: URL: (Accessed: 31/7/22)
7 Erythromycin-Resistant Streptococcus pneumoniae from Sterile Body Sites < 3% 3-9% 1-29% > 3% Source: EARSS. Available from: URL: (Accessed: 31/7/22)
8 Erythromycin-Resistant Streptococcus pneumoniae from Community-Acquired Respiratrory Tract Infections, 1998 no data -5% 5.1-1% 1.1-3% >3% Sources: Alexander Project, FINRES, STRAMA and DANMAP.
9 Lower use of macrolides (less exposed, shorter duration) Lower use of other antimicrobials Better compliance (dose, intervals) More rational utilization of antimicrobials? Lower Percentage of Erythromycin-R S. pneumoniae in Community-Acquired RTIs Different population? Age (extremes) Respiratory and other diseases Pre-school facilities Long-term care? Better living conditions Socio-economic status Climate? Less travel Different clones Less cross- transmission? Better protection against disease? Vaccination Breast feeding
10 Source: Cars O, et al. Lancet 21; 357:
11 Is It Relevant to Examine Overall Antibiotic Consumption? (1)! Overall antibiotic consumption (no. DDD) is related to no. antibiotic prescriptions and no. persons exposed to antibiotics! It only accounts for some aspects of antibiotic misuse, e.g. prescribed when not indicated, duration too long, but cannot account for errors in dosing or low compliance! Nevertheless, if the antibiotic course prescribed is not completed, then it is probably used at another occasion
12 Is It Relevant to Examine Overall Antibiotic Consumption? (2)! Antibiotics have an effect not only on the patients who are treated but also an effect on other patients and the environment! Relationship between antibiotic use and resistance is an ecological problem!! There is room for improvement considering the extent of variations both in the amount and the pattern of use among European countries
13 Erythromycin-Resistant Streptococcus pneumoniae and Macrolide Consumption in EU Member States, E rythrom ycin-resistant S. pneum oniae in 1998 (% ) Consum ption of m acrolides and lincosam ides in prim ary health care in 1997 (D D D /1, inh.-days) Sources: Alexander Project, FINRES, STRAMA, DANMAP, and Cars O, et al. Lancet 21; 357:
14 Source for resistance data: Alexander Project. Source for antimicrobial consumption data: Cars O, et al. Lancet 21; 357: STATENS SERUM INSTITUT %Erythromycin-R S. pneumoniae (Logodds transf.) and Antimicrobial Consumption in Europe Independent variable (ATC group) No. EU countries R 2 P Tetracyclines (J1A) <.1 NS Extended spectrum penicillins (J1CA, Ln tr.).74 <.1 Beta-lactamase sensitive penicil. (J1CE, Ln tr.).49 (-).5 Beta-lactamase resistant penicillins(j1cf) <.1 (-) NS Cephalosporins (J1DA).55.3 Trimethoprim (J1EA, Ln tr.) <.1 NS Macrolides and lincosamides (J1F).82 <.1 Fluoroquinolones (J1MA, Ln tr.).32.4 Other antibacterials (from ATC group J1). NS
15 12 Patients Interviews and Misuse of Antibiotics, Saved part of course for future use (%) 4 2 Claimed to finish course (%) UK France Belgium Turkey Italy Morocco Columbia Spain Thailand Source: Pechère J-C. Clin Infect Dis 21; 33 (Suppl 3): S17-S173.
16 %Erythromycin-R S. pneumoniae (Logodds transf.) and Factors That Might Facilitate Cross-Transmission Independent variable Preschool children taking up offers of preschool services (%) Population whose daily caring activities prevent them from undertaking the same amount of paid work (%) Persons living in households with children (%) Persons in overcrowded households (%, Ln transf.) Households lacking at least one of three basic amenities, i.e. bath, toilet or hot water (%, Ln transf.) Persons living below the poverty line (%, Ln tr.) Nights spent in EU countries with high %Ery-R S.p. (per 1, inh.-days, incl. domestic, Ln transf.) No. EU countries Sources: Danish National Institute of Social Research, EC Eurostat, and European Travel Commission (ETC) Tourism Statistics R (-) < P.6 NS.3.5 NS.6.6
17 %Erythromycin-R S. pneumoniae (Logodds transf.) and Susceptibility to/protection against Disease Independent variable Population whose age is <= 4 years (%) Population whose age is >65 years (%) Daily cigarette smokers (%) Households that cannot afford to keep home adequately warm (%, Ln transf.) Distributed doses of pneumococcal vaccine (per 1, inhabitants, 1996, Ln transf.) Infants breastfed at 3 months of age (%, Ln tr.) Persons with at least 3 hours of physical activity (leisure) in a typical week (%) No. EU countries <.1 (-) <.1.47 (-).29 (-) Sources: U.S. Bureau of the Census, EC Eurostat, WHO Regional Office for Europe, and Fedson DS. Clin Infect Dis 1998;26: R 2 P NS NS NS NS NS.1.5
18 Multiple Linear Regression Models for Prediction of %Erythromycin-R S. pneumoniae (Logodds transf.): Preliminary Results Independent variable β t P (Constant) <.1 Macrolides and lincosamides (J1F) <.1 R 2 =.817 Independent variable β t P Macrolides and lincosamides (J1F) Infants breastfed at 3 months of age (%, Ln tr.) R 2 =.959
19 Factor Analysis (PCA) of %ERSP (Logodds transf.) and Other Variables: Preliminary Results (1) Variable %Erythromycin-R S. pneumoniae (Logodds tr.) Macrolides and lincosamides (J1F) Cephalosporins (J1DA) Extended spectrum penicillins (J1CA, Ln transf.) Beta-lactamase sensitive penicil. (J1CE, Ln trsf.) Fluoroquinolones (J1MA, Ln transf.) Persons with at least 3 hours of physical activity (leisure) in a typical week (%) Infants breastfed at 3 months of age (%, Ln transf.) Persons in overcrowded households (%, Ln transf.) Persons living in households with children (%) Component
20 Factor Analysis (PCA) of %ERSP (Logodds transf.) and Other Variables: Preliminary Results (2) ln(sup1_room) rysp))
21 Source: EARSS, May 2. Available from: URL: STATENS SERUM INSTITUT Penicillin-Non Susceptible Streptococcus pneumoniae (PNSP) from Sterile Sites, 2 %PNSP no data < >3
22 Source: Bronzwaer SLAM, et al. Emerg Infect Dis 22; 8: STATENS SERUM INSTITUT Penicillin-Non Susceptible S. pneumoniae from Sterile Sites ( , log odds transf.) & Consumption of Beta-Lactams (1997) in the EU
23 %PNSP (Logodds transf.) and Antimicrobial Consumption in Europe Independent variable (ATC group) No. EU countries R 2 P Tetracyclines (J1A) <.1 NS Extended spectrum penicillins (J1CA, Ln tr.).66 <.1 Beta-lactamase sensitive penicil. (J1CE, Ln tr.).31 (-).4 Beta-lactamase resistant penicillins(j1cf) <.1 (-) NS Cephalosporins (J1DA).74 <.1 Trimethoprim (J1EA, Ln tr.) <.1 NS Macrolides and lincosamides (J1F).71 <.1 Fluoroquinolones (J1MA, Ln tr.).26.6 Other antibacterials (from ATC group J1).18 NS Source for resistance data: EARSS. Source for antimicrobial consumption data: Cars O, et al. Lancet 21; 357:
24 Multiple Linear Regression Model for Prediction of %PNSP (Logodds transf.): Preliminary Results Independent variable β t P (Constant) <.1 Cephalosporins (J1DA) <.1 R 2 =.74
25 Nalidixic Acid-Resistant Escherichia coli from Community-Acquired Uncomplicated UTIs in Women, ECO-SENS Project, no data <3% 3.1-6% 6.1-1% >1% Source: Kahlmeter G. Clin Microbiol Infect 21;7(Suppl 1): 86.
26 %Nalidixic Acid-Resistant E. coli (Logodds transf.) and Antimicrobial Consumption in Europe Independent variable (ATC group) No. EU countries R 2 P Tetracyclines (J1A).11 NS Extended spectrum penicillins (J1CA, Ln tr.).31.4 Beta-lactamase sensitive penicil. (J1CE, Ln tr.).64 (-).1 Beta-lactamase resistant penicillins(j1cf) <.1 (-) NS Cephalosporins (J1DA).2 NS Trimethoprim (J1EA, Ln tr.) <.1 (-) NS Macrolides and lincosamides (J1F).35.3 Fluoroquinolones (J1MA, Ln tr.).49.5 Other antibacterials (from ATC group J1).15 NS Source for resistance data: Kahlmeter G, et al. ECO.SENS. Source for antimicrobial consumption data: Cars O, et al. Lancet 21; 357:
27 Pathways of Antimicrobial Use in Primary Health Care Infection / Microorganism Prescription of antimicrobials Patient Over-the-counter dispensation of antimicrobials GP or specialist Pharmacist
28 Pathways of Antimicrobial Use in Primary Health Care (1) Infection / Microorganism Prescription of antimicrobials Patient Over-the-counter dispensation of antimicrobials GP or specialist Pharmacist
29 Different Susceptibility to/protection Against Infectious Diseases or Incidence of Community-Acquired Infectious Diseases?! Demography! Incidence of certain diseases, e.g. diabetes, cancer! Living conditions: overcrowding, day care, hygiene! Protecting factors: breastfeeding, vaccinations! Incidence of community-acquired infections: bacterial RTIs, influenza-like illness! Prevalence of resistance among communityacquired bacteria
30 Source: U.S. Bureau of the Census, WHO HFA database & EC Eurostat. STATENS SERUM INSTITUT Characteristics of the Population of 3 EU Member States, (1) Belgium Netherlands Denmark Population (million inhab.) Pop. -4 year old (%) Pop. > 65 year old (%) Urban population (%, WHO) Pop. density (inhab./km 2 ) Pop. in overcrowded homes (%) Pop.below poverty line (%) Pop. cannot afford to keep home adequately warm(%) Pop. without at least one of bath, toilet or hot water (%) 7 1 3
31 Influenza-Like Illness Activity and Overall Consumption of Systemic Antibacterials (ATC J1) in Primary Health Care, EU Member States, 1997 Influenza-Like Illness Activity, 1997 Source: FluNet. Available from: Consumption of antibacterials for systemic use ATC J1 (DDD per 1, inh-days) 5 4 DDD/1, inh.-days No repororadic/loregional No activity Sporadic Regional / / No report / Local Widespread
32 Overall Consumption of Systemic Antibacterials (ATC J1) in Primary Health Care and Breastfeeding, EU Member States, Consum ption of antibacterials for system ic use A TC J1 (DDD per 1, inh-days, 1997) R 2 =.28 P=.5 See also: Breastfeeding & Respiratory Illness During Childhood Wilson AC, et al. BMJ 1998;316: Infants breastfed at 3 m onths (%, , UK : at 4 m ths) Source: Health For All database, WHO.
33 Source: WHO Health For All database & EC Eurostat. STATENS SERUM INSTITUT Characteristics of the Population of 3 EU Member States, (2) Belgium Netherlands Denmark Daily smokers (%) Persons living in households with children (%) Preschool children taking up offers of preschool services (%) Respiratory diseases (no./1,) 1, ,448 Distrib. doses pneumococcal vaccine (no./1, inhab., 1996) Pop. with at least 3 hours of physical activity (leisure) in typical week (%) Infants breastfed at 3 months (%)
34 Labelling of Disease and Attitude Towards Upper Respiratory Tract Infections Flanders Netherlands "A cold" "Bronchitis" "Flu" Unlabelled (e.g., coughing, runny nose) Other (e.g., "sinusitis", "angina") Consulting a doctor Self-medication Nursing one's illness Source: Deschepper R, et al. Pat. Educ. Counsel. 22;48:
35 Prescription of Antimicrobials and Bacteriological Testing for Acute Tonsillitis, Prescribed antibiotics (%) - penicillin V (%) - amoxicillin (%) - macrolide (%) Bacteriological tests (%) No test, prescribed antibiotics (%) Belgium (n=44 pts) Netherlands (n=62 pts) Source: Touw-Otten FWMM & Staehr Johansen K. Family Pract. 1992;9:
36 Pathways of Antimicrobial Use in Primary Health Care (2) Infection / Microorganism Prescription of antimicrobials Patient Over-the-counter dispensation of antimicrobials GP or specialist Pharmacist
37 Factors that Influence Prescription (1): Related to the Patient! Cultural differences: perceived severity of illness! Social issues: pressure to be back at work/day care! Economical issues: income vs. price! Education and information: information campaigns! Health care system and regulation: cost of GP consultation, price of antimicrobials after reimbursement, direct access to specialists(?)! Promotion: direct-to-consumer advertising
38 Factors that Influence Prescription (2): Related to the GP or the Specialist! Cultural differences: willingness to help! Education and information: information campaigns, guidelines, drug compendia, registered indications for a specific antibiotic, promotional material provided by representatives! Health care system and regulation: type of healthcare system, rostering of patients, GP remuneration, working hours, point-of-care diagnostic tests, economical incentives, fear of litigation! Pharmaceutical industry and promotion: competition among pharmaceutical companies, intensity of promotional activity to GPs/specialists
39 Source: Deschepper R, et al. Pat. Educ. Counsel. 22;48: STATENS SERUM INSTITUT Attitude Towards Upper Respiratory Tract Infections, by Region and Religion Catholic, Catholic, Protestant, Nonchurchg., FL (n=6) NL (n=3) NL (n=8) FL (n=9) Nonchurchg., NL (n=4) Healing power of body (%) Fear of complications (%) Belief in antibiotics - sceptic (%) strong believer (%) 5 44 Use of antibiotics during the past 5 years - none/low (%) high/very high (%) 5 44
40 What About Cultural Differences in the European Union? 5 5 Consumption of antibacterials for systemic use ATC J1 (DDD per 1, inh-days) DDD/1, inh.-days P=.1 Majority protestant Majority catholics Majority Majority protestants catholics WELL, INSTEAD OF ALWAYS POINTING AT CULTURAL DIFFERENCES TO EXCUSE OUR LACK OF ACTION OR PREVIOUS MISTAKES, MAY BE WE COULD LEARN FROM (OTHER) DIFFERENCES AMONG COUNTRIES OR REGIONS AND IDENTIFY AREAS FOR IMPROVEMENT!
41 Antimicrobial Prescribing Attitudes of GPs Can Be Modified Through Peer-Review/Education!! Netherlands: peer-review groups (incl. collaborating pharmacist), mandatory clinical audits every 2 or 4 weeks (pharmacist reviews prescriptions)! Belgium: no such peer-review groups! Denmark: Audit Project Odense (APO), voluntary audits and reviews, originally for Danish counties, now expanding in other European countries Source: Coenen S, et al. Lancet 21;358:1272; Thiadens HA, et al. Lancet 21;358:1272-3; Audit Project Odense, 21 report.
42 Impact of a Public Campaign for a More Rational Use of Antibiotics in Belgium, 11/2-3/21! Expect antibiotic for flu : 49% resp. (before) vs. 3% (after)! Expect antibiotic for sore throat: 32% (before) vs. 18% (after)! Less antibiotic to avoid resistance: 64% (before) vs. 75% (after)! Antibiotics must be protected: 13% (before) vs. 25% (after)! Total antibiotic sales decreased by approx. 1% Source: Beauraind I, et al. Personal communication.
43 Characteristics of Spanish vs. Danish Compendia Dimensions 3x21x7 cm 3x21x5 cm 17x11x2.5 cm Weight 3.1 kg 1.8 kg 38 g Main classif. by company by disease+alph. by disease Financing pharm. industry pharm. industry med. assoc. Guidelines no no yes (27 pages)
44 Characteristics of Primary Health Care Systems in Four EU Member States, 1997 Belgium Netherlands Denmark Sweden GP/1, inh Remuneration GPs Fee Capitation/Fee Fee Salary/Fee Rostering of patients No Yes Yes Yes Referral to specialists No Yes Yes Yes Patient pays for: - consultations - antibiotics Partially 15 25% No No No 5 1% Max./year Max./year Source: Hendrickx E, et al. 41st ICAAC, Chicago (IL), 16-19/12/21, #41.
45 Overall Consumption of Systemic Antibacterials (ATC J1) in Primary Health Care, Fee-for-Service and Rostering of Patients by GPs, EU, 1997 Consumption of antibacterials for systemic use ATC J1 (DDD per 1, inh-days) DDD/1, inh.-days NS Salary/capitation Fee-for-service Salary or Fee-forcapitation service Consumption of antibacterials for systemic use ATC J1 (DDD per 1, inh-days) DDD/1, inh.-days P <.1 Rostering No rostering Rostering No rostering of patients of patients Sources: Cars O, et al. Lancet 21; 357: , and Highlights on Health, WHO/EURO.
46 Tetracycline-R S. aureus Blood Isolates (%, 5-month moving average) STATENS SERUM INSTITUT Monthly Tetracycline Prescription Rate and Tetracycline Resistance in S. aureus Blood Isolates, Denmark, 1/ / Change in subsidization: from 5 to % (1/1996) Tetracycline Use (# prescriptions per 1, inhabitants) Source: Johansen HL, Danish Medicines Agency, and Elsberg C, Statens Serum Inst., 2.
47 Cost After Reimbursement and Consumption of Tetracyclines and Fluoroquinolones in Primary Health Care, EU Member States, Consum ption of tetracyclines for system ic use A TC J1A (DDD per 1, inh-days, 1997) [ ] [ ] A verage cost of 1 D D D of oral tetracyclin e after reim b u rsem en t (PPP US$, 1998) C onsum ption of fluoroquinolones fo r system ic use ATC J1M A (DDD per 1, inh-days,1997) [ ] [ ] A verage cost of 1 DDD of oral fluoroquinolone after re im bursem ent (P P P US$,1998) Sources: Sources: Cars O, et al. Lancet 21; 357: , and EudraMat, April 1998.
48 Ex-Factory Price and Number of Brands of Tetracyclines and Fluoroquinolones on Market, EU Member States, 1998 E x -fa c to ry p rice of 1 DDD of oral te tra c y c line (PPP US$, 1998) E x -fa c to ry price of 1 DDD of oral fluoroquinolone (P P P US$,1998) Oralte tra c y c line product nam es (N o., incl. brands and generics, 1998) Oralfluoroquinolone product nam es (N o.,incl.brands and generics,1998) Source: EudraMat, April 1998.
49 Overall Consumption of Fluoroquinolones (ATC J1MA) in Primary Health Care, Companies and Brands of Antibiotics, EU Member States, 1997 C onsum ption of te tra c yc lines fo r system ic use ATC J1A (DDD per 1, inh-days,1997) NS ( ) Oraltetracycline product nam es (N o.,incl.brands and generics,1998) Consum ption of fluoroquinolones for system ic use A TC J1M A (DDD per 1, inh-days, 1997) ( ) ( ) ( ) ( ) R 2 =.36 P= Oralfluoroquinolone product nam es (N o., incl. brands and generics) Sources: Sources: Cars O, et al. Lancet 21; 357: , and EudraMat, April 1998.
50 Overall Consumption of Systemic Antibacterials (ATC J1) in Primary Health Care, Companies and Brands of Antibiotics, EU Member States, 1997 Consum ption of antibacterials for system ic use A TC J1 (DDD per 1, inh-days) R 2 =.52 P=.8 ( ) ( ) ( ) Consum ption of antibacterials for system ic use A TC J1 (DDD per 1, inh-days) R 2 =.42 P=.1 ( ) Com panies m arketing antibiotics (N o.) Oralantibiotic product nam es (N o., incl. brands and generics) Sources: Sources: Cars O, et al. Lancet 21; 357: , and EudraMat, April 1998.
51 Pathways of Antimicrobial Use in Primary Health Care (3) Infection / Microorganism Prescription of antimicrobials Patient Over-the-counter dispensation of antimicrobials GP or specialist Pharmacist
52 Over-The-Counter (OTC) Dispensation of Antimicrobials in Europe! Anecdotal evidence from colleagues! Spain: 42% of 1, households reported having antimicrobial packages at home. Only 2/3 of these packages were the result of a physician s prescription Orero A, et al. Med Clin (Barc) 1997; 19: ! Greece: 69% and 86% of pharmacists offered antibiotics when presented with a high-fever and a low-fever rhinosinusitis scenario, respectively Contopoulos-Ioannidis DG, et al. Clin Infect Dis 21; 33: ! EC-funded project Self-medication with Antibiotics started on 1st October, 22
53 Overall Consumption of Systemic Antibacterials (ATC J1) in Primary Health Care and Consumption of Medicines Without Prescription, EU, E I FIN A UK S DK IR L C onsum ption of medicines without prescription (% interview ed,1996) R 2 =.37 P=.2 Consum ption of antibacterials for system ic use A TC J1 (DDD per 1, inh-days, 1997) Consum ption of m edicines without prescription (% int., 1996) Sources: Eurobarometer 44.3, European Commission; Cars O, et al. Lancet 21; 357:
54 Consumption of Medicines Without Prescription, No. Inhabitants per Pharmacy, and Annual Revenues from Sales of Pharmaceuticals per Pharmacy, EU, Consum ption of m edicines without prescription (% pop., 1996) , 1, 15, 2, No. inhabitants per public pharm acy (1997) Annualrevenues from sales of pharm aceuticals per public pharm acy (M illion PPP US$, 1997) R 2 =.59 P=.1 5, 1, 15, 2, No. inhabitants per public pharm acy (1997) Sources: Eurobarometer 44.3, European Commission in Key Data on Health 2, Eurostat; and GIRP and IMS Health.
55 Conclusions! Food for thought! A substantial part of the observed differences in resistance are certainly due to different levels and patterns antimicrobial use! Better understand determinants of antimicrobial use in Europe and generate hypotheses for interventions! Study the possible adverse effects of restrictive and conservative antimicrobial use!! Some missing data should soon be provided by European collaborative projects, e.g. ESAC (primary health care and hospitals), ARPAC (mainly hospitals), SAR (self-medication with antibiotics)
Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector
Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector Niels Frimodt-Møller Professor, MD DMSc Dept. of Clinical Microbiology Hvidovre Hospital, Copenhagen,
More informationWhat is the problem? Latest data on antibiotic resistance
European Antibiotic Awareness Day 2009 What is the problem? Latest data on antibiotic resistance Zsuzsanna Jakab, ECDC Director Launch Seminar for EAAD Stockholm, 18 November 2009 Fluoroquinolone-resistant
More informationClinical microbiologist/id vs. Pharmacist in infectious diseases: Co-operation or confrontation?
Clinical microbiologist/id vs. Pharmacist in infectious diseases: Co-operation or confrontation? Niels Frimodt-Møller Professor (clinical microbiology), MD, DMSc National Center for Antimicrobials and
More informationStratégie et action européennes
Résistance aux antibiotiques : une impasse thérapeutique? Implications nationales et internationales Stratégie et action européennes Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union ESAC-Net surveillance data November 2016 Provision of reliable and comparable national antimicrobial consumption data is a prerequisite
More informationEuropean Antibiotic Awareness Day
Initiating a pan-european health campaign - experiences from setting up the European Antibiotic Awareness Day Dr Ülla-Karin Nurm Head of Public Health Development Section, Public Health Capacity and Communication
More informationQuelle politique antibiotique pour l Europe? Dominique L. Monnet
Quelle politique antibiotique pour l Europe? Dominique L. Monnet National Center for Antimicrobials & Infection Control Statens Serum Institut, Copenhagen, Denmark Opinion of the Section for Protection
More informationPublic policy to reduce antibiotic resistance Prof. Niels Frimodt-Moller
Public Policy to Reduce Antibiotic Resistance Niels Frimodt-Moller, Professor, MD DMSc Head, Antibiotic Research National Center for Antimicrobials and Infection Control Statens Serum Institut Copenhagen,
More informationHSE - Health Protection Surveillance Centre Surveillance of Antimicrobial Consumption in Ireland
Surveillance of Antimicrobial Consumption in Ireland Ajay Oza A European Study on the Relationship between Antimicrobial Use and Antimicrobial Resistance (1998-1999) Bronzwaer et al 2002 Emerging Infectious
More informationStop overuse of antibiotics in humans rational use
Stop overuse of antibiotics in humans rational use Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections (ARHAI) European Centre
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union November 2012 Highlights on antibiotic consumption Antibiotic use is one of the main factors responsible for the development and
More informationECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013
ECDC activities on antimicrobial resistance & healthcare-associated infections (ARHAI Programme) Ülla-Karin Nurm, ECDC Tallinn, 13 May 2013 What is the European Union? 27 Member States 24 official languages
More informationAMR epidemiological situation: ECDC update
One Health Network on Antimicrobial Resistance (AMR) AMR epidemiological situation: ECDC update Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI)
More informationRelationship Between Antibiotic Consumption and Resistance in European Hospitals
Relationship Between Antibiotic Consumption and Resistance in European Hospitals Dominique L. Monnet National Center for Antimicrobials and Infection Control, Statens Serum Institut, Copenhague, Danemark
More informationAntimicrobial Resistance and Papua New Guinea WHY is it important? HOW has the problem arisen? WHAT can we do?
Antimicrobial Resistance and Papua New Guinea WHY is it important? HOW has the problem arisen? WHAT can we do? John Ferguson, John Hunter Hospital, University of Newcastle, NSW, Australia Infectious Diseases
More informationStratégies et actions au niveau européen et international: populations humaines
Stratégies et actions au niveau européen et international: populations humaines Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections
More informationHow is Ireland performing on antibiotic prescribing?
European Antibiotic Awareness Campaign 2016 November Webinar Series on Antibiotic Prescribing How is Ireland performing on antibiotic prescribing? Dr Rob Cunney National Clinical Lead HCAI AMR Clinical
More informationObjective 1/20/2016. Expanding Antimicrobial Stewardship into the Outpatient Setting. Disclosure Statement of Financial Interest
Expanding Antimicrobial Stewardship into the Outpatient Setting Michael E. Klepser, Pharm.D., FCCP Professor Pharmacy Practice Ferris State University College of Pharmacy Disclosure Statement of Financial
More informationSwedish strategies and methods to combat antibiotic resistance
Swedish strategies and methods to combat antibiotic resistance Stephan Stenmark MD, PhD, County Medical Officer Västerbotten County Council, Sweden Head of Department for communicable disease control and
More informationConsumption of antibiotics in hospitals. Antimicrobial stewardship.
Consumption of antibiotics in hospitals. Antimicrobial stewardship. Inge C. Gyssens MD PhD Radboud university medical center, Nijmegen, The Netherlands Hasselt University, Belgium 1. Antibiotic use in
More informationAntimicrobial Stewardship:
Antimicrobial Stewardship: Inpatient and Outpatient Elements Angela Perhac, PharmD afperhac@carilionclinic.org Disclosure I have no relevant finances to disclose. Objectives Review the core elements of
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22 December 2005 COM (2005) 0684 REPORT FROM THE COMMISSION TO THE COUNCIL ON THE BASIS OF MEMBER STATES REPORTS ON THE IMPLEMENTATION OF THE COUNCIL RECOMMENDATION
More informationAntimicrobial Resistance Update for Community Health Services
Antimicrobial Resistance Update for Community Health Services Elizabeth Beech Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England October 2015 elizabeth.beech@nhs.net Superbugs
More informationANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU
ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU Health and Food Safety John Paget (NIVEL) Dominique Lescure (NIVEL) Ann Versporten (University of Antwerp)
More informationHealth Service Executive Parkgate St. Business Centre, Dublin 8 Tel:
Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel: 01 635 2500 www.hse.ie Health Service Executive Oak House, Millennium Park, Naas, Co. Kildare Tel: 045 880 400 www.hse.ie The prevention
More informationThe threat of multidrug-resistant microorganisms and how to deal with it in Europe
The threat of multidrug-resistant microorganisms and how to deal with it in Europe Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial resistance and Healthcare-associated infections
More informationAntimicrobial resistance and antimicrobial consumption in Europe
Antimicrobial resistance and antimicrobial consumption in Europe Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Programme Vilnius, 28 November
More informationBelgian National Antibiotic Awareness Campaigns
Belgian National Antibiotic Awareness Campaigns Herman Goossens, Stijn De Corte, Samuel Coenen University of Antwerp and BAPCOC Joris Mateusen, Sarah Tulkens Absoluut Belgium Belgian National Antibiotic
More informationEuropean Antibiotic Awareness Day: Promoting prudent antibiotic use in Europe
European Antibiotic Awareness Day: Promoting prudent antibiotic use in Europe Dominique L. Monnet, Head of Disease Programme, Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Joint
More information3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats
Antibiotics --When Less is More Ralph Gonzales, MD, MSPH Associate Dean, Clinical Innovation School of Medicine VP, Clinical Innovation, UCSF Health Most Urgent Threats Serious Threats Multidrug-Resistant
More informationThe challenge of growing resistance
EXECUTIVE SUMMARY Around 2.4 million people could die in Europe, North America and Australia between 2015-2050 due to superbug infections unless more is done to stem antibiotic resistance. However, three
More informationSurveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe
Surveillance of Antimicrobial Resistance and Healthcare-associated Infections in Europe Carl Suetens, ECDC Presented by Håkan Hanberger ecdc.europa.eu Message/Questions from C Suetens to Workshop 7, MIE2009
More informationSEASONAL TRENDS IN ANTIBIOTIC USAGE AMONG PAEDIATRIC OUTPATIENTS
SEASONAL TRENDS IN ANTIBIOTIC USAGE AMONG PAEDIATRIC OUTPATIENTS Edita Alili-Idrizi, Msc Merita Dauti, Msc State University of Tetovo, Faculty of Medicine, Department of Pharmacy, Tetovo, R. of Macedonia
More informationHow do people obtain antibiotics in European countries: an overview
How do people obtain antibiotics in European countries: an overview Dominique L. Monnet, Programme Coordinator Senior Expert, Scientific Advice Unit & the National Antimicrobial Resistance Focal Points
More informationSECOND REPORT FROM THE COMMISSION TO THE COUNCIL
SECOND REPORT FROM THE COMMISSION TO THE COUNCIL ON THE BASIS OF MEMBER STATES REPORTS ON THE IMPLEMENTATION OF THE COUNCIL RECOMMENDATION (2002/77/EC) ON THE PRUDENT USE OF ANTIMICROBIAL AGENTS IN HUMAN
More informationCHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY
CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Antibiotics One of the most commonly used group of drugs In USA 23
More informationPrevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices
Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated
More informationEpidemiology and Economics of Antibiotic Resistance
Epidemiology and Economics of Antibiotic Resistance Eili Y. Klein February 17, 2016 Health Watch USA Meeting I. The burden of antibiotic resistance is a growing global threat, but hard numbers are lacking
More informationTandan, Meera; Duane, Sinead; Vellinga, Akke.
Provided by the author(s) and NUI Galway in accordance with publisher policies. Please cite the published version when available. Title Do general practitioners prescribe more antimicrobials when the weekend
More informationAntibiotic resistance and prescribing in Australia: current attitudes and practice of GPs
CSIRO PUBLISHING Healthcare Infection, 2013, 18, 147 151 http://dx.doi.org/10.1071/hi13019 Antibiotic resistance and prescribing in Australia: current attitudes and practice of GPs Rachel Hardy-Holbrook
More informationWHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health
New WHO report provides the most comprehensive picture of antibiotic resistance to date, with data from 114 countries 30 APRIL 2014 GENEVA - A new report by WHO its first to look at antimicrobial resistance,
More informationHealthcare Facilities and Healthcare Professionals. Public
Document Title: DOH Guidelines for Antimicrobial Stewardship Programs Document Ref. Number: DOH/ASP/GL/1.0 Version: 1.0 Approval Date: 13/12/2017 Effective Date: 14/12/2017 Document Owner: Applies to:
More informationProf. Otto Cars. We are overconsuming a global resource. It is a collective responsibility by governments, supranational organisatons
What are the consequences of rising antibiotic resistance for Sweden? Prof. Otto Cars Chairman The Swedish Strategic programme against antibiotic resistance (Strama) We are overconsuming a global resource
More informationBirgitte Borck Høg, Senior Scientific Officer Helle Korsgaard, Senior Scientific Officer Tine Hald, Professor National Food Institute, DTU
Methods and challenges in data and information sharing in the Danish Integrated Surveillance for Antimicrobials and Antimicrobial Resistance system (DANMAP) Birgitte Borck Høg, Senior Scientific Officer
More informationUNDERSTANDING SOUTH AFRICA'S CONSUMPTION OF ANTIMICROBIALS
UNDERSTANDING SOUTH AFRICA'S CONSUMPTION OF ANTIMICROBIALS Pharmacy Society of South Africa Conference 2018 Ruth Lancaster Contents 1. Background AMR National Strategic Plan 2. Sources of antimicrobial
More informationWorkplan on Antibiotic Usage Management
IMPACT Forum: Antibiotic Guideline in Perspective Workplan on Antibiotic Usage Management Dr. Raymond Yung Consultant Microbiologist PYNEH 20 April 2002 May 2002 Dr. Raymond Yung 1 Objective 1. Heighten
More informationAntimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report
Antimicrobial consumption and resistance in humans in the EU and conclusions from the ECDC-EFSA- EMA JIACRA report Dominique L. Monnet, on behalf of ECDC Antimicrobial Resistance and Healthcare-Associated
More informationNATIONAL ACTION PLAN ON ANTIBIOTICS IN HUMAN HEALTHCARE
NATIONAL ACTION PLAN ON ANTIBIOTICS IN HUMAN HEALTHCARE Three measurable goals for a reduction of antibiotic consumption towards 2020 JULY 2017 Table of Contents Foreword: Antibiotics or not?... 2 Introduction:
More informationAntimicrobial consumption
Antimicrobial consumption Annual Epidemiological Report for 2017 Key facts Twenty-seven countries, comprising 25 EU Member States and two EEA countries (Iceland and Norway) reported data on antimicrobial
More informationESAC s Surveillance by Point Prevalence Measurements. by author
ESAC s Surveillance by Point Prevalence Measurements Herman Goossens, MD, PhD ESAC Co-ordinator VAXINFECTIO, Laboratory of Medical Microbiology University of Antwerp, Belgium Outline Background Point Prevalence
More informationThe UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England
The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England Chief Medical Officer - Annual Report 2013 Antimicrobial resistance poses catastrophic
More informationThe International Collaborative Conference in Clinical Microbiology & Infectious Diseases
The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of
More informationDANMAP and VetStat. Monitoring resistance and antimicrobial consumption in production animals
DANMAP and VetStat Monitoring resistance and antimicrobial consumption in production animals Flemming Bager Head Division for Risk Assessment and Nutrition Erik Jacobsen Danish Veterinary and Food Administration
More informationViResiST: its contribution to our knowledge of the relationship between antimicrobial use and resistance. Dominique L. Monnet
ViResiST: its contribution to our knowledge of the relationship between antimicrobial use and resistance Dominique L. Monnet About antibiotics... As soon as we use it, we loose it The more we use it, the
More informationVaccination as a potential strategy to combat Antimicrobial Resistance in the elderly
Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly Wilbur Chen, MD, MS 22-23 March 2017 WHO meeting on Immunization of the Elderly The Problem Increasing consumption
More informationMethodology for surveillance of antimicrobials use among out-patients in Delhi
Indian J Med Res 129, May 2009, pp 555-560 Methodology for surveillance of antimicrobials use among out-patients in Delhi Anita Kotwani, Kathleen Holloway * & R.R. Chaudhury ** Department of Pharmacology,
More informationAntibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011
Antibiotic Resistance Antibiotic Resistance: A Growing Concern Judy Ptak RN MSN Infection Prevention Practitioner Dartmouth-Hitchcock Medical Center Lebanon, NH Occurs when a microorganism fails to respond
More informationAntimicrobial Resistance. Tackling the Burden in the European Union. Briefing note for EU/EEA countries
Antimicrobial Resistance Tackling the Burden in the European Union Briefing note for EU/EEA countries Antimicrobial Resistance Tackling the Burden in the European Union Contents Key messages 03 Use of
More informationResponsible use of antibiotics
Responsible use of antibiotics Uga Dumpis MD, PhD Department of Infectious Diseases and Infection Control Pauls Stradiņs Clinical University Hospital Challenges in the hospitals Antibiotics are still effective
More informationDANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme
DANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme Hanne-Dorthe Emborg Department of Microbiology and Risk Assessment National Food Institute, DTU Introduction The DANMAP
More informationAn Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings?
An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings? Dr. Andrew Morris Antimicrobial Stewardship ProgramMt. Sinai Hospital University Health Network amorris@mtsinai.on.ca andrew.morris@uhn.ca
More informationInternational Food Safety Authorities Network (INFOSAN) Antimicrobial Resistance from Food Animals
International Food Safety Authorities Network (INFOSAN) 7 March 2008 INFOSAN Information Note No. 2/2008 - Antimicrobial Resistance Antimicrobial Resistance from Food Animals SUMMARY NOTES Antimicrobial
More informationWho is the Antimicrobial Steward?
Who is the Antimicrobial Steward? J. Njeri Wainaina, MD FACP Assistant Professor of Medicine Division of Infectious Diseases and Section of Perioperative Medicine Disclosures None 1 Objectives Highlight
More informationThe Commission activities on AMR (focus on zoonotic issues)
The Commission activities on AMR (focus on zoonotic issues) R.M. Peran i Sala European Commission, DG SANCO London, 15.09.2011 1. DG SANCO and AMR High priority status given on AMR in DG SANCO EU Commission
More informationMRSA in the United Kingdom status quo and future developments
MRSA in the United Kingdom status quo and future developments Dietrich Mack Chair of Medical Microbiology and Infectious Diseases The School of Medicine - University of Wales Swansea P R I F Y S G O L
More informationAntibiotic resistance: the rise of the superbugs
Antibiotic resistance: the rise of the superbugs Allen Cheng Associate Professor of Infectious Diseases Epidemiology, Alfred Health; Monash University About me Specialist in infectious diseases Head, Infection
More informationEuropean challenges on antimicrobial resistance from a one health perspective Danish EU Presidency meeting, Copenhagen, 14 March 2012
European challenges on antimicrobial resistance from a one health perspective Danish EU Presidency meeting, Copenhagen, 14 March 2012 Your Royal Highness Crown Princess Mary, Ministers, Distinguished guests,
More informationSWEDRES 2001 STRAMA. A Report on Swedish Antibiotic Utilisation and Resistance in Human Medicine
SWEDRES 2001 A Report on Swedish Antibiotic Utilisation and Resistance in Human Medicine STRAMA The Swedish Strategic Programme for the Rational Use of Antimicrobial Agents Table of contents 1. Preface...
More informationAntibiotic stewardship in long term care
Antibiotic stewardship in long term care Shira Doron, MD Associate Professor of Medicine Division of Geographic Medicine and Infectious Diseases Tufts Medical Center Boston, MA Consultant to Massachusetts
More informationAntimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS
Antimicrobial Stewardship in the Long Term Care and Outpatient Settings Carlos Reyes Sacin, MD, AAHIVS Disclosure Speaker and consultant in HIV medicine for Gilead and Jansen Pharmaceuticals Objectives
More information4. The use of antibiotics without a prescription in seven EU Member States
4. The use of antibiotics without a prescription in seven EU Member States Main findings The results are based upon telephone interviews in seven Member States (Cyprus, Estonia, Greece, Hungary, Italy,
More informationHalting Infections in Long Term Care
Results of HALT Study 2013 Halting Infections in Long Term Care HALT Seminar Novemeber 2014 DR Nuala O Connor ICGP Lead HCAI AMR DR Bartley Cryan Consultant microbiologist CUH Dr Paul Gallagher Consultant
More informationData for action The Danish approach to surveillance of the use of antimicrobial agents and the occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark 2 nd edition,
More informationAntimicrobial Stewardship: efective implementation for improved clinical outcomes
The Challenge of MDR and XDR infections; Barcelona September 2018 Antimicrobial Stewardship: efective implementation for improved clinical outcomes José Miguel Cisneros Herreros Infectious Diseases Department
More informationMarc Decramer 3. Respiratory Division, University Hospitals Leuven, Leuven, Belgium
AAC Accepts, published online ahead of print on April 0 Antimicrob. Agents Chemother. doi:./aac.0001- Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationSpecial Eurobarometer 478. Summary. Antimicrobial Resistance
Antimicrobial Resistance Survey requested by the European Commission, Directorate-General for Health and Food Safety and co-ordinated by the Directorate-General for Communication This document does not
More informationBELIEFS AND PRACTICES OF PARENTS ON THE USE OF ANTIBIOTICS FOR THEIR CHILDREN WITH UPPER RESPIRATORY TRACT INFECTION
PIDSP Journal 2009 Vol 10No.1 Copyright 2009 BELIEFS AND PRACTICES OF PARENTS ON THE USE OF ANTIBIOTICS FOR THEIR CHILDREN WITH UPPER RESPIRATORY TRACT INFECTION Micheline Joyce C. Salonga, MD* ABSTRACT
More informationAntibiotic stewardship a role for Managed Care. Doug Burgoyne, PharmD. CEO, Veridicus Health
Antibiotic stewardship a role for Managed Care Doug Burgoyne, PharmD CEO, Veridicus Health GRIP: Global Respiratory Infection Partnership Aim: To decrease inappropriate antibiotic use by developing a consistent
More informationANTIBIOTICS: TECHNOLOGIES AND GLOBAL MARKETS
ANTIBIOTICS: TECHNOLOGIES AND GLOBAL MARKETS PHM025D March 2016 Neha Maliwal Project Analyst ISBN: 1-62296-252-4 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
More informationTalk outline. History of resistance. The start of antibiotic resistance: Penicillin. Bacterial evolution vs mankind s ingenuity
At UN, global leaders commit to act on antimicrobial resistance 21 September 2016 Antibiotic resistance: the need for innovative global and local policy in response to market failure. Dr. Ken Harvey MB
More informationRESISTANCE, USE, INTERVENTIONS. Hugh Webb
RESISTANCE, USE, INTERVENTIONS Hugh Webb EU Initiatives: EARSS and ESAC. Antimicrobial Use and Resistance The Relationship. Bias and confounding in published studies. Mathematical modelling of resistance
More informationUse of antibiotics around the world
Use of antibiotics around the world Françoise Van Bambeke, PharmD, PhD Pharmacologie cellulaire et moléculaire & Centre de pharmacie clinique, Louvain Drug Research Institute Université catholique de Louvain,
More informationChallenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S.
Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S. Overview of benchmarking Antibiotic Use Scott Fridkin, MD, Senior Advisor for Antimicrobial
More informationThe European AMR Challenge - strategic views from the human perspective -
The European AMR Challenge - strategic views from the human perspective - World Health Organization Regional Office for Europe Dr Danilo Lo Fo Wong Senior Adviser on Antimicrobial Resistance Division of
More informationFIS Resistance Surveillance: The UK Landscape. Alasdair MacGowan Chair BSAC Working Party on Antimicrobial Resistance Surveillance
FIS 2013 Resistance Surveillance: The UK Landscape Alasdair MacGowan Chair BSAC Working Party on Antimicrobial Resistance Surveillance A statement of the obvious Good quality surveillance data on resistant
More informationANTIBIOTIC STEWARDSHIP
ANTIBIOTIC STEWARDSHIP S.A. Dehghan Manshadi M.D. Assistant Professor of Infectious Diseases and Tropical Medicine Tehran University of Medical Sciences Issues associated with use of antibiotics were recognized
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Background Why Antimicrobial Stewardship 30-50% of antibiotic use in hospitals are unnecessary or inappropriate Appropriate antimicrobial use is a medication-safety and patient-safety
More informationANTIMICROBIAL STEWARDSHIP: ADVANCING PATIENT CARE BY IMPROVING MEDICATION USE
ANTIMICROBIAL STEWARDSHIP: ADVANCING PATIENT CARE BY IMPROVING MEDICATION USE ANTHONY M. CASAPAO, PHARM.D. ASSISTANT PROFESSOR OF PHARMACY PRACTICE HUSSON UNIVERSITY SCHOOL OF PHARMACY CLINICAL INFECTIOUS
More informationPer Capita Antibiotic Consumption: How Does a North American Jurisdiction Compare with Europe?
MAJOR ARTICLE Per Capita Antibiotic Consumption: How Does a North American Jurisdiction Compare with Europe? David M. Patrick, 1 Fawziah Marra, 1 James Hutchinson, 3 Dominique L Monnet, 4 Helen Ng, 1 and
More informationAntibiotic usage in nosocomial infections in hospitals. Dr. Birgit Ross Hospital Hygiene University Hospital Essen
Antibiotic usage in nosocomial infections in hospitals Dr. Birgit Ross Hospital Hygiene University Hospital Essen Infection control in healthcare settings - Isolation - Hand Hygiene - Environmental Hygiene
More informationA Retrospective Study on Antibiotic Use in Different Clinical Departments of a Teaching Hospital in Zawiya, Libya
Ibnosina J Med BS 13 ARTICLE A Retrospective Study on Antibiotic Use in Different Clinical Departments of a Teaching Hospital in Zawiya, Libya Prakash Katakam, Abdulbaset A. Elfituri, Zaidoon H. Ramadan,
More informationAntimicrobial consumption
SURVEILLANCE REPORT Annual Epidemiological Report for 2016 Antimicrobial consumption Key facts Twenty-nine countries, including 27 EU Member States and two EEA countries (Iceland and Norway) reported data
More informationVolume 2; Number 16 October 2008
Volume 2; Number 16 October 2008 What s new this month NHS Lincolnshire have launched a public information campaign designed to raise public awareness of the risks associated with the inappropriate use
More informationprof. dr. Bojana Beović, dr. med.
How To Improve ntibiotic Use In Hospitals prof. dr. ojana eović, dr. med. University Medical entre Ljubljana Slovenia Evidence-based antibiotic. Team (II-III) III) stewardship 2. ollaboration with
More informationAntibiotic Stewardship Program (ASP) CHRISTUS SETX
Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:
More informationEpidemiology of human MRSA in Europe and public health importance of animal strains
Epidemiology of human MRSA in Europe and public health importance of animal strains Carl Suetens, ECDC, 08/04/2008 ecdc.europa.eu Why was ECDC established? Emerging and re-emerging communicable diseases
More informationBTSF. Better Training for Safer Food Initiative. Antimicrobial Resistance One Health approach MEASURE UNITS
Better Training for Safer Food Initiative Antimicrobial Resistance One Health approach MEASURE UNITS BTSF This presentation is delivered under contract with the Consumers, Health, Agriculture and Food
More informationAntimicrobial Stewardship in the Outpatient Setting. ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016
Antimicrobial Stewardship in the Outpatient Setting ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016 Abbreviations AMS - Antimicrobial Stewardship Program OP - Outpatient OPS - Outpatient Setting
More informationrunning head: SUPERBUGS Humphreys 1
running head: SUPERBUGS Humphreys 1 Superbugs GCH 360 Term Paper Assignment Kelly Humphreys April 30, 2014 SUPERBUGS Humphreys 2 Introduction The World Health Organization (WHO) recognizes antibiotic resistance
More informationQuestionnaire on antibiotics
Questionnaire on antibiotics 1. Antibiotic consumption Antibiotics are medications which are sometimes used to treat infections. There are several different types of antibiotics; penicillin is the most
More information